Matthew J Sweet

Prof. Matthew J Sweet

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2009 in Science
Verified
Journal Article
Closed access
PDF file
TRTara Roberts
Tara Roberts
Adi IdrisAdi Idris
Adi Idris
JDJasmyn A. Dunn
Jasmyn A. Dunn
GKGreg M. Kelly
Greg M. Kelly
CBCarol M. Burnton
Carol M. Burnton
KSKatryn J. Stacey
Katryn J. Stacey
The mammalian innate immune system is activated by foreign nucleic acids. Detection of double-stranded DNA (dsDNA) in the cytoplasm triggers characteristic antiviral responses and macrophage cell death. Cytoplasmic dsDNA rapidly activated caspase 3 and caspase 1 in bone marrow–derived macrophages. We identified the HIN-200 family member and candidate lupus susceptibility factor, p202, as a dsDNA binding protein that bound stably and rapidly to transfected DNA. Knockdown studies showed p202 to be an inhibitor of DNA-induced caspase activation. Conversely, the related pyrin domain–containing HIN-200 factor, AIM2 (p210), was required for caspase activation by cytoplasmic dsDNA. This work indicates that HIN-200 proteins can act as pattern recognition receptors mediating responses to cytoplasmic dsDNA.

1 July 1996 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
MSMatthew J Sweet
Matthew J Sweet
DHDavid A Hume
David A Hume

3 August 2018 in Science Immunology
Verified
Journal Article
Closed access
PDF file
KCKaiwen W. Chen
Kaiwen W. Chen
MMMercedes Monteleone
Mercedes Monteleone
DBDave Boucher
Dave Boucher
GSGabriel Sollberger
Gabriel Sollberger
DRDivya Ramnath
Divya Ramnath
KSKate Schroder
Kate Schroder
Neutrophil extrusion of neutrophil extracellular traps (NETs) and concomitant cell death (NETosis) provides host defense against extracellular pathogens, whereas macrophage death by pyroptosis enables defense against intracellular pathogens. We report the unexpected discovery that gasdermin D (GSDMD) connects these cell death modalities. We show that neutrophil exposure to cytosolic lipopolysaccharide or cytosolic Gram-negative bacteria (Salmonella ΔsifA and Citrobacter rodentium) activates noncanonical (caspase-4/11) inflammasome signaling and triggers GSDMD-dependent neutrophil death. GSDMD-dependent death induces neutrophils to extrude antimicrobial NETs. Caspase-11 and GSDMD are required for neutrophil plasma membrane rupture during the final stage of NET extrusion. Unexpectedly, caspase-11 and GSDMD are also required for early features of NETosis, including nuclear delobulation and DNA expansion; this is mediated by the coordinate actions of caspase-11 and GSDMD in mediating nuclear membrane permeabilization and histone degradation. In vivo application of deoxyribonuclease I to dissolve NETs during murine Salmonella ΔsifA challenge increases bacterial burden in wild-type but not in Casp11−/− and Gsdmd −/− mice. Our studies reveal that neutrophils use an inflammasome- and GSDMD-dependent mechanism to activate NETosis as a defense response against cytosolic bacteria.

1 January 2011 in Critical Reviews in Immunology
Verified
Journal Article
Closed access
MRManuela Rossol
Manuela Rossol
HHHolger Heine
Holger Heine
UMUndine Meusch
Undine Meusch
DQDagmar Quandt
Dagmar Quandt
CKCarina Klein
Carina Klein
SHSunna Hauschildt
Sunna Hauschildt
Lipopolysaccharide (LPS) from Gram-negative bacteria is one of the most potent innate immune-activating stimuli known. Here we review the current understanding of LPS effects on human monocyte and macrophage function. We provide an overview of LPS signal transduction with attention given to receptor cooperativity and species differences in LPS responses, as well as the role of tyrosine phosphorylation and lysine acetylation in signalling. We also review LPS-regulated transcription, with emphasis on chromatin remodeling and primary versus secondary transcriptional control mechanisms. Finally, we review the regulation and function of LPS-inducible cytokines produced by human monocytes and macrophages including TNFα, the IL-1 family, IL-6, IL-8, the IL-10 family, the IL-12 family, IL-15 and TGFβ.

1 July 2011 in Trends in Immunology
Verified
Journal Article
Closed access
MSMelanie R. Shakespear
Melanie R. Shakespear
MHMaria A. Halili
Maria A. Halili
KIKatharine Irvine
Katharine Irvine
DFDavid P. Fairlie
David P. Fairlie
MSMatthew J Sweet
Matthew J Sweet

8 February 2011 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
KAKylie A Alexander
Kylie A Alexander
MCMing K Chang
Ming K Chang
EMErin R Maylin
Erin R Maylin
TKThomas Kohler
Thomas Kohler
RMRalph Müller
Ralph Müller
APAllison R Pettit
Allison R Pettit
Bone-lining tissues contain a population of resident macrophages termed osteomacs that interact with osteoblasts in vivo and control mineralization in vitro. The role of osteomacs in bone repair was investigated using a mouse tibial bone injury model that heals primarily through intramembranous ossification and progresses through all major phases of stabilized fracture repair. Immunohistochemical studies revealed that at least two macrophage populations, F4/80+Mac-2−/lowTRACP− osteomacs and F4/80+Mac-2hiTRACP− inflammatory macrophages, were present within the bone injury site and persisted throughout the healing time course. In vivo depletion of osteomacs/macrophages (either using the Mafia transgenic mouse model or clodronate liposome delivery) or osteoclasts (recombinant osteoprotegerin treatment) established that osteomacs were required for deposition of collagen type 1+ (CT1+) matrix and bone mineralization in the tibial injury model, as assessed by quantitative immunohistology and micro–computed tomography. Conversely, administration of the macrophage growth factor colony-stimulating factor 1 (CSF-1) increased the number of osteomacs/macrophages at the injury site significantly with a concurrent increase in new CT1+ matrix deposition and enhanced mineralization. This study establishes osteomacs as participants in intramembranous bone healing and as targets for primary anabolic bone therapies. © 2011 American Society for Bone and Mineral Research.